Definitive Stock Analysis

DH
 Stock
  

USD 12.36  0.03  0.24%   

The big decline in price over the last few months for Definitive Healthcare could raise concerns from stockholders as the firm is trading at a share price of 12.36 on 873,639 in volume. The company executives failed to add value to investors and position the firm supply of money to exploit market volatility in November. However, diversifying your holdings with Definitive Healthcare Corp or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.82. This high volatility is attributed to the latest market swings and not-so-good earnings reports for some of the Definitive Healthcare partners.
Continue to Investing Opportunities.
  
The Definitive Healthcare stock analysis report makes it easy to digest most publicly released information about Definitive Healthcare and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Definitive Stock analysis module also helps to analyze the Definitive Healthcare price relationship with some important fundamental indicators such as market cap and management efficiency.

Definitive Stock Analysis Notes

About 98.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.4. Some equities with similar Price to Book (P/B) outperform the market in the long run. Definitive Healthcare has Price/Earnings To Growth (PEG) ratio of 1.03. The entity recorded a loss per share of 0.16. The firm had not issued any dividends in recent years. Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts. Definitive Healthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 676 people. To learn more about Definitive Healthcare Corp call Robert JD at 508 720 4224 or check out https://www.definitivehc.com.

Definitive Healthcare Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Definitive Healthcare's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Definitive Healthcare Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Definitive Healthcare generated a negative expected return over the last 90 days
Definitive Healthcare has high historical volatility and very poor performance
The company generated the yearly revenue of 166.15 M. Annual Net Loss to common stockholders was (51.02 M) with gross profit of 146.73 M.
Definitive Healthcare has a poor financial position based on the latest SEC disclosures
Over 98.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Revolution Healthcare Acquisition Corp. Will Redeem Public Shares - Yahoo Finance

Definitive Healthcare Upcoming and Recent Events

Earnings reports are used by Definitive Healthcare to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Definitive Healthcare previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report14th of February 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End14th of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Definitive Largest EPS Surprises

Earnings surprises can significantly impact Definitive Healthcare's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-11-03
2022-09-300.050.060.0120 
2022-08-04
2022-06-300.050.060.0120 
2022-05-05
2022-03-310.040.050.0125 
View All Earnings Estimates

Definitive Healthcare SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Definitive Healthcare prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Definitive Healthcare investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Definitive Healthcare specific information freely available to individual and institutional investors to make a timely investment decision.
4th of August 2022
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
26th of May 2022
Submission of Matters to a Vote of Security Holders
View
5th of May 2022
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Results of Operations and Financial Condition
View
23rd of February 2022
Financial Statements and Exhibits. Other Events. Results of Operations and Financial Condition
View
14th of February 2022
Unclassified Corporate Event
View
11th of February 2022
Unclassified Corporate Event
View

Definitive Market Capitalization

The company currently falls under 'Mid-Cap' category with a market capitalization of 1.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Definitive Healthcare's market, we take the total number of its shares issued and multiply it by Definitive Healthcare's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Definitive Profitablity

Definitive Healthcare's profitability indicators refer to fundamental financial ratios that showcase Definitive Healthcare's ability to generate income relative to its revenue or operating costs. If, let's say, Definitive Healthcare is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Definitive Healthcare's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Definitive Healthcare's profitability requires more research than a typical breakdown of Definitive Healthcare's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin (PM) of (0.13) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.17) %, which signifies that for every 100 dollars of sales, it has a net operating loss of 0.0.
Last ReportedProjected for 2022
Return on Average Assets(0.0081) (0.008739) 
Return on Average Equity(0.0153) (0.0165) 
Return on Invested Capital 0.026  0.0379 
Return on Sales 0.05  0.05 

Management Efficiency

The entity has Return on Asset (ROA) of (0.0108) % which means that for every 100 dollars spent on asset, it generated loss of $0.0108. This is way below average. Likewise, it shows return on total equity (ROE) of (0.0317) %, which implies that it produced no returns to current stockholders. Definitive Healthcare management efficiency ratios could be used to measure how well definitive healthcare manages its routine affairs as well as how well it operates its assets and liabilities. Definitive Healthcare Return on Invested Capital is most likely to slightly decrease in the upcoming years. The last year's value of Return on Invested Capital was reported at 0.026. The current Return on Sales is estimated to increase to 0.05, while Return on Average Assets are projected to decrease to (0.008739) . Definitive Healthcare Average Assets are most likely to increase significantly in the upcoming years. The last year's value of Average Assets was reported at 1.93 Billion
Last ReportedProjected for 2022
Book Value per Share 9.50  10.46 
Enterprise Value over EBIT 419.40  416.95 
Enterprise Value over EBITDA 54.08  53.76 
Price to Book Value 4.18  4.15 
Tangible Assets Book Value per Share 5.46  4.62 
Enterprise Value3.7 B3.7 B
Tangible Asset Value502.1 M430.9 M
long Term Debt Total
263.8 M
non Current Liabilities Total
494.9 M
short Long Term Debt Total
270.7 M
interest Expense
25.9 M
total Operating Expenses
144.2 M
common Stock Total Equity
97 K

Technical Drivers

As of the 7th of December, Definitive Healthcare shows the coefficient of variation of (807.77), and Mean Deviation of 3.52. Definitive Healthcare technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyze and collected data for nineteen technical drivers for Definitive Healthcare Corp, which can be compared to its rivals. Please confirm Definitive Healthcare coefficient of variation, maximum drawdown, skewness, as well as the relationship between the information ratio and downside variance to decide if Definitive Healthcare is priced favorably, providing market reflects its regular price of 12.36 per share. Given that Definitive Healthcare has jensen alpha of (0.71), we urge you to verify Definitive Healthcare Corp's prevailing market performance to make sure the company can sustain itself at a future point.

Definitive Healthcare Price Movement Analysis

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Simple Moving Average indicator is calculated by adding the closing price of Definitive Healthcare for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Definitive Healthcare short-term fluctuations and highlight longer-term trends or cycles.
.

Definitive Healthcare Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Definitive Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Definitive Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Definitive Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Krantz Jason Ronald over three weeks ago via Macroaxis 
Purchase by Krantz Jason Ronald of 450000 shares of Definitive Healthcare
Maack Jonathan over three weeks ago via Macroaxis 
Acquisition by Maack Jonathan of 546303 shares of Definitive Healthcare subject to Rule 16b-3
Musslewhite Robert W over a month ago via Macroaxis 
Payment of 70658 shares by Musslewhite Robert W of Definitive Healthcare subject to Rule 16b-3
Chilukuri Sastry over two months ago via Macroaxis 
Acquisition by Chilukuri Sastry of 26588 shares of Definitive Healthcare subject to Rule 16b-3
Krantz Jason Ronald over two months ago via Macroaxis 
Payment of 10597 shares by Krantz Jason Ronald of Definitive Healthcare subject to Rule 16b-3
Sea Vii Management Llc over three months ago via Macroaxis 
Conversion by Sea Vii Management Llc of 1016000 shares of Definitive Healthcare
Larsen Jill over six months ago via Macroaxis 
Acquisition by Larsen Jill of 14545 shares of Definitive Healthcare subject to Rule 16b-3
Haywood Jeffrey Charles over six months ago via Macroaxis 
Sale by Haywood Jeffrey Charles of 18315 shares of Definitive Healthcare
Booth Richard Douglas over six months ago via Macroaxis 
Purchase by Booth Richard Douglas of 2374 shares of Definitive Healthcare
Krantz Jason Ronald over a year ago via Macroaxis 
Disposition of 688165 shares by Krantz Jason Ronald of Definitive Healthcare subject to Rule 16b-3
Winters Kathleen A over a year ago via Macroaxis 
Acquisition by Winters Kathleen A of 6737 shares of Definitive Healthcare subject to Rule 16b-3
Musslewhite Robert W over a year ago via Macroaxis 
Acquisition by Musslewhite Robert W of 650000 shares of Definitive Healthcare subject to Rule 16b-3

Definitive Healthcare Predictive Daily Indicators

Definitive Healthcare intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Definitive Healthcare stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Definitive Healthcare Forecast Models

Definitive Healthcare time-series forecasting models is one of many Definitive Healthcare's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Definitive Healthcare's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Definitive Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Definitive Healthcare prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Definitive shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Definitive Healthcare. By using and applying Definitive Stock analysis, traders can create a robust methodology for identifying Definitive entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin 0.41  0.48 
Gross Margin 0.76  0.83 
Profit Margin(0.1) (0.10) 

Current Definitive Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Definitive analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Definitive analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
44.88Hold8Odds
Definitive Healthcare Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Definitive analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Definitive stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Definitive Healthcare, talking to its executives and customers, or listening to Definitive conference calls.
Definitive Analyst Advice Details

Definitive Stock Analysis Indicators

Definitive Healthcare Corp stock analysis indicators help investors evaluate how Definitive Healthcare stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Definitive Healthcare shares will generate the highest return on investment. By understating and applying Definitive Healthcare stock analysis, traders can identify Definitive Healthcare position entry and exit signals to maximize returns.
Begin Period Cash Flow24774000.00
Total Stockholder Equity873206000.00
Country NameUSA
Property Plant And Equipment Net5069000.00
Retained Earnings-17677000.00
Cash And Short Term Investments387498000.00
Retained Earnings Total Equity-17677000.00
Cash387498000.00
50 Day M A13.6042
Net Interest Income-25871000.00
Total Current Liabilities117795000.00
Forward Price Earnings58.1395
Investments-46731000.00
Common Stock Total Equity97000.00
Interest Expense25871000.00
Common Stock Shares Outstanding87519184.00
Total Cashflows From Investing Activities-46731000.00
Tax Provision675000.00
CodeDH
Other Current Assets20723000.00
Accounts Payable4651000.00
Net Debt-116815000.00
Currency CodeUSD
Other Operating Expenses184848000.00
Non Current Assets Total1664431000.00
Liabilities And Stockholders Equity1485932000.00
Non Currrent Assets Other12615000.00
Continue to Investing Opportunities. Note that the Definitive Healthcare information on this page should be used as a complementary analysis to other Definitive Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Complementary Tools for Definitive Stock analysis

When running Definitive Healthcare price analysis, check to measure Definitive Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Definitive Healthcare is operating at the current time. Most of Definitive Healthcare's value examination focuses on studying past and present price action to predict the probability of Definitive Healthcare's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Definitive Healthcare's price. Additionally, you may evaluate how the addition of Definitive Healthcare to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Is Definitive Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Definitive Healthcare. If investors know Definitive will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Definitive Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
1.2 B
Quarterly Revenue Growth YOY
0.332
Return On Assets
(0.0108) 
Return On Equity
(0.0317) 
The market value of Definitive Healthcare is measured differently than its book value, which is the value of Definitive that is recorded on the company's balance sheet. Investors also form their own opinion of Definitive Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Definitive Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Definitive Healthcare's market value can be influenced by many factors that don't directly affect Definitive Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Definitive Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine Definitive Healthcare value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Definitive Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.